I-MAB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.82 USD | -1.62% |
|
+1.68% | -4.21% |
| Apr. 18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
| Apr. 15 | I-Mab Announces Chief Medical Officer Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| I-MAB | Other Pharmaceuticals | -1.62% | +1.68% | -4.21% | -44.00% | - | 147M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- IMAB Stock
- Charts I-Mab
- Comparison Chart